The susceptibility to infection by Leishmania panamensis and the sensitivity to drugs differ according to the macrophage type

dc.contributor.authorCarol V. Mesa
dc.contributor.authorDiana L. Muñoz
dc.contributor.authorMónica Echeverry
dc.contributor.authorIván Darío Vélez
dc.contributor.authorSara M. Robledo
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:53:12Z
dc.date.available2026-03-22T16:53:12Z
dc.date.issued2010
dc.description.abstractIntroduction: In vitro systems are useful in the evaluation of compounds with biological activity determining the cytotoxic and leishmanicidal activity of the candidates. Objective: To identify the mammalian cell that allows the optimal in vitro infection by Leishmania and therefore, identify the suitable system for the in vitro evaluation of leishmanicidal activity of drugs. Methodology: The susceptibility to the infection by L. panamensis was evaluated according to the Infective Concentration 50 tested by light microscopy and flow citometry; the intracellular survival of amastigotes was determined by fluorescence microscopy and the sensitivity to amphotericine B and meglumine antimoniate was evaluated by spectrophotometry. Results: The primary culture cells were more susceptible to the in vitro infection by L. panamensis because they did require fewer parasites per cell ratio to achieve the 50% infection rate whereas the intracellular survival of parasites was better in the U-937 cells. All cells showed differential sensitivity to amphotericine B and meglumine antimoniate. Conclusion: The U-937 cells are the most suitable model for the in vitro infection by L. panamensis because: a) they are a cell line with unlimited growth where transformation into macrophages can be induced. b) The susceptibility to infection by L. panamensis is similar to that observed in primary cultures macrophages and, c) They allow the intracellular survival of amastigotes after the infection process. In addition the U-937 cells are less sensitive to the action of the commonly drugs used as a control in the screening of compounds with leishmanicidal activity. Salud UIS 2010; 42: 200-211
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/60897
dc.language.isoen
dc.sourceCentro Nacional de Enfermedades Tropicales
dc.subjectAmastigote
dc.subjectMeglumine antimoniate
dc.subjectIntracellular
dc.subjectIn vitro
dc.subjectBiology
dc.subjectMacrophage
dc.subjectLeishmania
dc.subjectCutaneous leishmaniasis
dc.subjectMicrobiology
dc.subjectCell culture
dc.titleThe susceptibility to infection by Leishmania panamensis and the sensitivity to drugs differ according to the macrophage type
dc.typearticle

Files